Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 77

1.

9β Polymorphism of the glucocorticoid receptor gene appears to have limited impact in patients with Addison's disease.

Ross IL, Dandara C, Swart M, Lacerda M, Schatz D, Blom DJ.

PLoS One. 2014 Jan 23;9(1):e86350. doi: 10.1371/journal.pone.0086350. eCollection 2014.

2.

Investigation of glucocorticoid receptor polymorphisms in relation to metabolic parameters in Addison's disease.

Ross IL, Levitt NS, Van der Merwe L, Schatz DA, Johannsson G, Dandara C, Pillay TS, Blom DJ.

Eur J Endocrinol. 2013 Feb 15;168(3):403-12. doi: 10.1530/EJE-12-0808. Print 2013 Mar.

PMID:
23239757
3.

BClI polymorphism of the glucocorticoid receptor gene is associated with increased obesity, impaired glucose metabolism and dyslipidaemia in patients with Addison's disease.

Giordano R, Marzotti S, Berardelli R, Karamouzis I, Brozzetti A, D'Angelo V, Mengozzi G, Mandrile G, Giachino D, Migliaretti G, Bini V, Falorni A, Ghigo E, Arvat E.

Clin Endocrinol (Oxf). 2012 Dec;77(6):863-70. doi: 10.1111/j.1365-2265.2012.04439.x.

4.

Increased cardiovascular risk in South African patients with Addison's disease.

Ross IL, Bergthorsdottir R, Levitt NS, Schatz DA, Johannsson G, Marais AD.

Horm Metab Res. 2013 Nov;45(12):905-10. doi: 10.1055/s-0033-1351259. Epub 2013 Aug 5.

PMID:
23918685
5.

Cardiovascular risk factors in patients with Addison's disease: a comparative study of South African and Swedish patients.

Ross IL, Bergthorsdottir R, Levitt N, Dave JA, Schatz D, Marais D, Johannsson G.

PLoS One. 2014 Mar 6;9(6):e90768. doi: 10.1371/journal.pone.0090768. eCollection 2014.

6.

Polymorphisms in the glucocorticoid receptor gene that modulate glucocorticoid sensitivity are associated with rheumatoid arthritis.

van Oosten MJ, Dolhain RJ, Koper JW, van Rossum EF, Emonts M, Han KH, Wouters JM, Hazes JM, Lamberts SW, Feelders RA.

Arthritis Res Ther. 2010;12(4):R159. doi: 10.1186/ar3118. Epub 2010 Aug 21.

7.

BclI polymorphism of the glucocorticoid receptor gene is associated with increased bone resorption in patients on glucocorticoid replacement therapy.

Koetz KR, van Rossum EF, Ventz M, Diederich S, Quinkler M.

Clin Endocrinol (Oxf). 2013 Jun;78(6):831-7. doi: 10.1111/cen.12096.

PMID:
23134110
8.

A cytotoxic T lymphocyte antigen-4 (CTLA-4) gene polymorphism is associated with autoimmune Addison's disease in English patients.

Kemp EH, Ajjan RA, Husebye ES, Peterson P, Uibo R, Imrie H, Pearce SH, Watson PF, Weetman AP.

Clin Endocrinol (Oxf). 1998 Nov;49(5):609-13.

PMID:
10197076
9.

A glucocorticoid receptor gene haplotype (TthIII1/ER22/23EK/9beta) is associated with a more aggressive disease course in multiple sclerosis.

van Winsen LM, Manenschijn L, van Rossum EF, Crusius JB, Koper JW, Polman CH, Uitdehaag BM.

J Clin Endocrinol Metab. 2009 Jun;94(6):2110-4. doi: 10.1210/jc.2008-2194. Epub 2009 Mar 24. Erratum in: J Clin Endocrinol Metab. 2009 Jul;94(7):2674. Crusius, Bart A [corrected to Crusius, J Bart A].

PMID:
19318444
10.

Functional polymorphism of the glucocorticoid receptor gene associates with mania and hypomania in bipolar disorder.

Spijker AT, van Rossum EF, Hoencamp E, DeRijk RH, Haffmans J, Blom M, Manenschijn L, Koper JW, Lamberts SW, Zitman FG.

Bipolar Disord. 2009 Feb;11(1):95-101. doi: 10.1111/j.1399-5618.2008.00647.x.

PMID:
19133972
11.

The relation between two polymorphisms in the glucocorticoid receptor gene and body mass index, blood pressure and cholesterol in obese patients.

Di Blasio AM, van Rossum EF, Maestrini S, Berselli ME, Tagliaferri M, Podestà F, Koper JW, Liuzzi A, Lamberts SW.

Clin Endocrinol (Oxf). 2003 Jul;59(1):68-74.

PMID:
12807506
12.

No evidence of association of CTLA4 polymorphisms with Addison's disease.

Pérez de Nanclares G, Martín-Pagola A, Ramón Bilbao J, Vázquez F, Castaño L.

Autoimmunity. 2004 Sep-Nov;37(6-7):453-6.

PMID:
15621571
13.

Genetic variants in the glucocorticoid receptor gene (NR3C1) and cardiovascular disease risk. The Leiden 85-plus Study.

Kuningas M, Mooijaart SP, Slagboom PE, Westendorp RG, van Heemst D.

Biogerontology. 2006 Aug;7(4):231-8. Epub 2006 May 5.

PMID:
16676134
14.

Sex specific associations between common glucocorticoid receptor gene variants and hypothalamus-pituitary-adrenal axis responses to psychosocial stress.

Kumsta R, Entringer S, Koper JW, van Rossum EF, Hellhammer DH, Wüst S.

Biol Psychiatry. 2007 Oct 15;62(8):863-9. Epub 2007 Aug 23.

PMID:
17716631
15.

Glucocorticoid replacement therapy and pharmacogenetics in Addison's disease: effects on bone.

Løvås K, Gjesdal CG, Christensen M, Wolff AB, Almås B, Svartberg J, Fougner KJ, Syversen U, Bollerslev J, Falch JA, Hunt PJ, Chatterjee VK, Husebye ES.

Eur J Endocrinol. 2009 Jun;160(6):993-1002. doi: 10.1530/EJE-08-0880. Epub 2009 Mar 12.

PMID:
19282465
16.

Glucocorticoid receptor polymorphism affects transrepression but not transactivation.

van den Akker EL, Russcher H, van Rossum EF, Brinkmann AO, de Jong FH, Hokken A, Pols HA, Koper JW, Lamberts SW.

J Clin Endocrinol Metab. 2006 Jul;91(7):2800-3. Epub 2006 May 9.

PMID:
16684836
17.

Two common haplotypes of the glucocorticoid receptor gene are associated with increased susceptibility to cardiovascular disease in men with familial hypercholesterolemia.

Koeijvoets KC, van der Net JB, van Rossum EF, Steyerberg EW, Defesche JC, Kastelein JJ, Lamberts SW, Sijbrands EJ.

J Clin Endocrinol Metab. 2008 Dec;93(12):4902-8. doi: 10.1210/jc.2008-0813. Epub 2008 Sep 23.

PMID:
18812484
18.

Glucocorticoid receptor gene and risk of cardiovascular disease.

van den Akker EL, Koper JW, van Rossum EF, Dekker MJ, Russcher H, de Jong FH, Uitterlinden AG, Hofman A, Pols HA, Witteman JC, Lamberts SW.

Arch Intern Med. 2008 Jan 14;168(1):33-9. doi: 10.1001/archinternmed.2007.41.

PMID:
18195193
19.

Glucocorticoid receptor polymorphisms modulate cardiometabolic risk factors in patients in long-term remission of Cushing's syndrome.

Roerink SH, Wagenmakers MA, Smit JW, van Rossum EF, Netea-Maier RT, Plantinga TS, Hermus AR.

Endocrine. 2016 Jul;53(1):63-70. doi: 10.1007/s12020-016-0883-z. Epub 2016 Feb 13.

20.

[Cardiovascular and metabolic impact of glucocorticoid substitution therapy in patients with Addison's disease].

Salah DB, Charfi N, Elleuch M, Kacem FH, Rekik N, Mnif M, Mnif F, Abid M.

Pan Afr Med J. 2018 Aug 6;30:251. doi: 10.11604/pamj.2018.30.251.12546. eCollection 2018. French.

Supplemental Content

Support Center